foscarnet has been researched along with succimer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Forster, IC; Murer, H; Ravera, S; Virkki, LV | 1 |
1 review(s) available for foscarnet and succimer
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for foscarnet and succimer
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Deciphering PiT transport kinetics and substrate specificity using electrophysiology and flux measurements.
Topics: Animals; Arsenates; Female; Foscarnet; Humans; Hydrogen-Ion Concentration; Kinetics; Lithium; Membrane Potentials; Microinjections; Models, Biological; Oocytes; Patch-Clamp Techniques; Phosphates; Phosphorus Radioisotopes; Sodium; Sodium Radioisotopes; Sodium-Phosphate Cotransporter Proteins, Type III; Succimer; Sulfates; Xenopus laevis; Xenopus Proteins | 2007 |